Clinical specimens and expression profile assays from the Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) were analyzed to identify the contribution of CD248 to RCC progression. The gene discussed is CD248; the disease is renal cell carcinoma.